Generation & Characterization of a Post-Checkpoint Inhibitor Mouse Tumor Model of Resistance
Time: 2:00 pm
day: Day 1 Track B PM
Details:
- Mouse models that mimic the patient population in the clinic who have acquired resistance to checkpoint therapies
- Combination efficacy of our clinical assets in the IO refractory tumor models
- Leveraging these findings to improve translation to benefit Post-CPI patients
